BibTex RIS Cite

Relationship Between Mood, Food and Nutrition

Year 2018, Issue: 4, 357 - 365, 01.12.2018

Abstract

Many foods that are consumed, affect the brain functions, including mind and cognition, while providing metabolic fuel for the body. The food we eat is not only necessary as a metabolic fuel for the body, it also influences brain functions including mind and cognition. Food can increase well-being, both physically and emotionally. The view that foods and nutrition contribute to both physical and emotional well-being, which affect emotional states and behaviors, is increasingly accepted. Furthermore, mood affects the individuals’ decisions on what kind of foods are consumed. It is known that deficiency of various nutrients not only leads to depressed mood and cognitive disfunction but also known to be contributive to aggressive behavior. The importance of signals in the brain-gut axis in the emergence of nutrition on mood, behavior and cognition are better understood today. In this article, information regarding the relationship between mood, food and nutrition has been reviewed

References

  • Jacquelyn H. Flaskerud Mood and Food. Issues in Mental Health Nursing 2015; 36:307–10. [CrossRef]
  • White BA, Horwath CC, Conner TS. Many apples a day keep the blues away – Daily experiences of negative and positive affect and food consumption in young adults. British Journal of Health Psychology 2013;18:782–98. [CrossRef]
  • Grosso G, Pajak A, Marventano S, Castellano S, Galvano F, Bucolo C, et al. Role of omega-3 fatty acids in the treatment of depressive disorders: A comprehensive meta-analysis of randomized clinical trials. PLOS ONE 2014; 9: e96905. [CrossRef]
  • Hennebelle M, Champeil-Potokar G, Lavialle M, Vancassel S, Denis I. Omega-3 polyunsaturated fatty acids and chronic stress- induced modulations of glutamatergic neurotransmission in the hippocampus. Nutrition Review 2014; 72: 99–112. [CrossRef]
  • Mischoulon D. The impact of omega-3 fatty acids on depressive disorders and suicidality. Journal of Clinical Psychiatry 2011;72,1574– 6. [CrossRef]
  • Prasad C. Food, mood and health: a neurobiological outlook. Brazilian Journal of Medical and Biological Research 1998;31,1517–27.
  • Logan AC, Jacka FN. Nutritional psychiatry research: an emerging discipline and its intersection with global urbanization, environmental challenges and the evolutionary mismatch. J Physiol Anthropol 2014;33:22. [CrossRef]
  • Gold SS. Eat your way happy. The mood boosting benefit of food. Yoga Journal 2015. [Erişim] (Erişim tarihi: 05.09.2018).
  • Hopf SM. You are what you eat: How food affects your mood. Dartmouth Undergraduate Journal of Science 2013. http://dujs. dartmouth.edu/2011/02/you-are-what-you-eat-how-food-affects- your-mood/#.V3PaHdKLTIU.
  • Strasser B, Gostner JM, Fuchs D. Mood, food, and cognition: role of tryptophan and serotonin. Curr Opin Clin Nutr Metab Care 2016;19:55–61. [CrossRef]
  • Stone TW, Darlington LG. The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders. Br J Pharmacol 2013;169:1211–27. [CrossRef]
  • Rakofsky JJ, Dunlop BW. Review of nutritional supplements fort the treatment of bipolar depression. Depression and Anxiety 2014;31:379–90. [CrossRef]
  • Lakhan SE, Vieira KF. Nutritional therapies for mental disorders. Nutrition Journal 2008; 7:2 [CrossRef]
  • Gostner JM, Becker K, Ueberall F, Fuchs D. The good and bad of antioxidant foods: an immunological perspective. Food Chem Toxicol 2015; 80:72–9. [CrossRef]
  • Sperner-Unterweger B, Fuchs D. Schizophrenia and psychoneuroimmunology: an integrative view. Curr Opin Psychiatry 2015; 28:201–6. [CrossRef]
  • Werner ER, Blau N, Thöny B. Tetrahydrobiopterin: biochemistry and pathophysiology. Biochem J 2011; 438:397–414. [CrossRef]
  • Wang Y, Kasper LH. The role of microbiome in central nervous system disorders. Brain, Behavior, and Immunity 2014; 38: 1–12. [CrossRef]
  • Lang UE, Beglinger C, Schweinfurth N, Walter M, Borgwardt S. Nutritional Aspects of Depression. Cell Physiol Biochem 2015;37:1029-43. [CrossRef]
  • Dash S, Clarke G, Berk M, Jacka FN. The gut microbiome and diet in psychiatry: focus on depression. Curr Opin Psychiatry. 2015;28:1-6. [CrossRef]
  • Leblhuber F, Geisler S, Steiner K, Fuchs D, Schütz B. Elevated fecal calprotectin in patients with Alzheimer’s dementia indicates leaky gut. J Neural Transm (Vienna). 2015;122:1319-22. [CrossRef]
  • Scott LV, Clarke G, Dinan TG: The brain-gut axis: a target for treating stress-related disorders. Mod Trends Pharmacopsychiatri 2013;28:90-9. [CrossRef]
  • Cryan JF, Dinan TG: Mind-altering microorganisms: the impact of the gut microbiota on brain and behavior. Nat Rev Neurosci 2012;13:701–12. [CrossRef]
  • Borre YE, O’Keeffe GW, Clarke G, Stanton C, Dinan TG, Cryan JF. Microbiota and neurodevelopmental windows: implications for brain disorders. Trends Mol Med 2014; 20:509-18. [CrossRef]
  • Miyake Y, Tanaka K, Okubo H, Sasaki S, Arakawa M. Intake of dairy products and calcium and prevalence of depressive symptoms during pregnancy in Japan: a cross-sectional study. BJOG 2015;122:336-43. [CrossRef]
  • Miki T, Kochi T, Eguchi M, Kuwahara K, Tsuruoka H, Kurotani K, et al. Dietary intake of minerals in relation to depressive symptoms in Japanese employees: the Furukawa Nutrition and Health Study. Nutrition 2015;31:686-90. [CrossRef]
  • Vashum KP, McEvoy M, Milton AH, McElduff P, Hure A, Byles J, et al. Dietary zinc is associated with a lower incidence of depression: findings from two Australian cohorts. J Affect Disord 2014;166:249- 57. [CrossRef]
  • Sawada T, Yokoi K. Effect of zinc supplementation on mood states in young women: a pilot study. Eur J Clin Nutr. 2010;64:331-3. [CrossRef]
  • Park Y, Park YS, Kim SH, Oh DH, Park YC. Supplementation of n-3 Polyunsaturated Fatty Acids for Major Depressive Disorder: A Randomized, Double-Blind, 12-Week, Placebo-Controlled Trial in Korea. Ann Nutr Metab 2015;66:141-8. [CrossRef]
  • McLeod MN, Golden RN. Chromium treatment of depression. Int J Neuropsychopharmacol 2000;3:311–4. [CrossRef]
  • Davidson JR, Abraham K, Connor KM, McLeod MN. Effectiveness of chromium in atypical depression: a placebo-controlled trial. Biol Psychiatry 2003;53:261–4.
  • Lang UE, Borgwardt S. Molecular mechanisms of depression: perspectives on new treatment strategies. Cell Physiol Biochem 2013;31:761-77. [CrossRef]
  • Bertone-Johnson ER, Hankinson SE, Forger NG, Powers SI, Willett WC, Johnson SR, et al. Plasma 25-hydroxyvitamin D and risk of premenstrual syndrome in a prospective cohort study. BMC Womens Health 2014;14:56. [CrossRef]
  • Hoang MT, Defina LF, Willis BL. Association between low serum 25-hydroxyvitamin D and depression in a large sample of healthy adults: the Cooper Center longitudinal study. Mayo Clin Proc 2011;86:1050–5. [CrossRef]
  • Yüksel RN, Altunsoy N, Tikir B, Cingi Külük M, Unal K, Goka S, Aydemir C, Goka E. Correlation between total vitamin D levels and psychotic psychopathology in patients with schizophrenia: therapeutic implications for add-on vitamin D augmentation. Ther Adv Psychopharmacol 2014;. 4: 268–75. [CrossRef]
  • McGrath J, Saari K, Hakko H, Jokelainen J, Jones P, Järvelin MR, et al. Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study. Schizophr Res 2004;67:237–45. [CrossRef]
  • Munoz CX, Johnson EC, McKenzie AL, Guelinckx I, Graverholt G, Casa DJ, et al. Habitual total water intake and dimensions of mood in healthy young women. Appetite 2015;92:81–6. [CrossRef]
  • Zhao G, Ford ES, Li C, Tsai C, Dhingra S, Balluz LS. Waist circumference, abdominal obesity, and depression among overweight and obese U.S. adults: national health and nutrition examination survey 2005- 2006. BMC Psychiatry 2011; 11: 130. [CrossRef]
  • Raheja UK, Fuchs D, Giegling I, Brenner LA, Rowner SF, Mohyuddin I, Weghuber D, Magge H, Rujescu D. In psychiatrically healthy individuals, overweight women but not men have lower tryptophan levels. Pteridines 2015; 26:79–84. [CrossRef]
  • Özenoğlu A, Ünal G. Açlık ve Şiddet. MÜSBED 2015;5:115-22. [CrossRef]
  • Voracek M, Tran US. Dietary tryptophan intake and suicide rate in industrialized nations. J Affect Disord 2007;98:259-62. [CrossRef]
  • Lankelma JM, Nieuwdorp M, de Vos WM, Wiersinga WJ. The gut microbiota in internal medicine: implications for health and disease. Neth J Med 2015;2:61-8.
  • Oriach CS, Robertson RC, Stanton C, Cryan JF, Dinan TG. Food for thought: The role of nutrition in the microbiota-gut-brain axis. Clinical Nutrition Experimental 2016; 6: 25-38. [CrossRef]
  • Dinan TG, Stanton C, Cryan JF. Psychobiotics: a novel class of psychotropic. Biol Psychiatry 2013;74:720-6. [CrossRef]
  • Cani PD, Delzenne NM. The gut microbiome as therapeutic target. Pharmacology and Therapeutics 2011: 130: 202–12. [CrossRef]

Duygu durumu, Besin ve Beslenme İlişkisi

Year 2018, Issue: 4, 357 - 365, 01.12.2018

Abstract

Tüketilen besinler vücudun metabolik enerji gereksinimini sağlamakla birlikte zihin ve bilişin de dahil olduğu birçok beyin fonksiyonlarını etkilerler. Besinler ve beslenmenin duygu durumu ve davranışları etkilediği hem fiziksel hem de duygusal iyilik haline katkıda bulunduğu görüşü giderek daha çok kabul görmektedir. Bundan başka, duygu durumu da bireyin ne tür besinleri tüketeceği yönündeki seçimlerini ve kararlarını etkilemektedir. Çeşitli besin ögeleri yetersizliğinin sadece bilişsel fonksiyonlarda zayıflama ve depresif ruh haline yol açmakla kalmayıp, saldırgan davranışların sergilenmesinde de etkili olduğu bilinmektedir. Beslenmenin duygudurumu, davranış ve biliş üzerine etkilerinin ortaya çıkmasında beyin-bağırsak eksenindeki sinyallerin önemi günümüzde daha iyi anlaşılmıştır. Bu yazıda duygudurumunun besinler ve beslenme ile ilişkisine yönelik bilgiler derlenmiştir

References

  • Jacquelyn H. Flaskerud Mood and Food. Issues in Mental Health Nursing 2015; 36:307–10. [CrossRef]
  • White BA, Horwath CC, Conner TS. Many apples a day keep the blues away – Daily experiences of negative and positive affect and food consumption in young adults. British Journal of Health Psychology 2013;18:782–98. [CrossRef]
  • Grosso G, Pajak A, Marventano S, Castellano S, Galvano F, Bucolo C, et al. Role of omega-3 fatty acids in the treatment of depressive disorders: A comprehensive meta-analysis of randomized clinical trials. PLOS ONE 2014; 9: e96905. [CrossRef]
  • Hennebelle M, Champeil-Potokar G, Lavialle M, Vancassel S, Denis I. Omega-3 polyunsaturated fatty acids and chronic stress- induced modulations of glutamatergic neurotransmission in the hippocampus. Nutrition Review 2014; 72: 99–112. [CrossRef]
  • Mischoulon D. The impact of omega-3 fatty acids on depressive disorders and suicidality. Journal of Clinical Psychiatry 2011;72,1574– 6. [CrossRef]
  • Prasad C. Food, mood and health: a neurobiological outlook. Brazilian Journal of Medical and Biological Research 1998;31,1517–27.
  • Logan AC, Jacka FN. Nutritional psychiatry research: an emerging discipline and its intersection with global urbanization, environmental challenges and the evolutionary mismatch. J Physiol Anthropol 2014;33:22. [CrossRef]
  • Gold SS. Eat your way happy. The mood boosting benefit of food. Yoga Journal 2015. [Erişim] (Erişim tarihi: 05.09.2018).
  • Hopf SM. You are what you eat: How food affects your mood. Dartmouth Undergraduate Journal of Science 2013. http://dujs. dartmouth.edu/2011/02/you-are-what-you-eat-how-food-affects- your-mood/#.V3PaHdKLTIU.
  • Strasser B, Gostner JM, Fuchs D. Mood, food, and cognition: role of tryptophan and serotonin. Curr Opin Clin Nutr Metab Care 2016;19:55–61. [CrossRef]
  • Stone TW, Darlington LG. The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders. Br J Pharmacol 2013;169:1211–27. [CrossRef]
  • Rakofsky JJ, Dunlop BW. Review of nutritional supplements fort the treatment of bipolar depression. Depression and Anxiety 2014;31:379–90. [CrossRef]
  • Lakhan SE, Vieira KF. Nutritional therapies for mental disorders. Nutrition Journal 2008; 7:2 [CrossRef]
  • Gostner JM, Becker K, Ueberall F, Fuchs D. The good and bad of antioxidant foods: an immunological perspective. Food Chem Toxicol 2015; 80:72–9. [CrossRef]
  • Sperner-Unterweger B, Fuchs D. Schizophrenia and psychoneuroimmunology: an integrative view. Curr Opin Psychiatry 2015; 28:201–6. [CrossRef]
  • Werner ER, Blau N, Thöny B. Tetrahydrobiopterin: biochemistry and pathophysiology. Biochem J 2011; 438:397–414. [CrossRef]
  • Wang Y, Kasper LH. The role of microbiome in central nervous system disorders. Brain, Behavior, and Immunity 2014; 38: 1–12. [CrossRef]
  • Lang UE, Beglinger C, Schweinfurth N, Walter M, Borgwardt S. Nutritional Aspects of Depression. Cell Physiol Biochem 2015;37:1029-43. [CrossRef]
  • Dash S, Clarke G, Berk M, Jacka FN. The gut microbiome and diet in psychiatry: focus on depression. Curr Opin Psychiatry. 2015;28:1-6. [CrossRef]
  • Leblhuber F, Geisler S, Steiner K, Fuchs D, Schütz B. Elevated fecal calprotectin in patients with Alzheimer’s dementia indicates leaky gut. J Neural Transm (Vienna). 2015;122:1319-22. [CrossRef]
  • Scott LV, Clarke G, Dinan TG: The brain-gut axis: a target for treating stress-related disorders. Mod Trends Pharmacopsychiatri 2013;28:90-9. [CrossRef]
  • Cryan JF, Dinan TG: Mind-altering microorganisms: the impact of the gut microbiota on brain and behavior. Nat Rev Neurosci 2012;13:701–12. [CrossRef]
  • Borre YE, O’Keeffe GW, Clarke G, Stanton C, Dinan TG, Cryan JF. Microbiota and neurodevelopmental windows: implications for brain disorders. Trends Mol Med 2014; 20:509-18. [CrossRef]
  • Miyake Y, Tanaka K, Okubo H, Sasaki S, Arakawa M. Intake of dairy products and calcium and prevalence of depressive symptoms during pregnancy in Japan: a cross-sectional study. BJOG 2015;122:336-43. [CrossRef]
  • Miki T, Kochi T, Eguchi M, Kuwahara K, Tsuruoka H, Kurotani K, et al. Dietary intake of minerals in relation to depressive symptoms in Japanese employees: the Furukawa Nutrition and Health Study. Nutrition 2015;31:686-90. [CrossRef]
  • Vashum KP, McEvoy M, Milton AH, McElduff P, Hure A, Byles J, et al. Dietary zinc is associated with a lower incidence of depression: findings from two Australian cohorts. J Affect Disord 2014;166:249- 57. [CrossRef]
  • Sawada T, Yokoi K. Effect of zinc supplementation on mood states in young women: a pilot study. Eur J Clin Nutr. 2010;64:331-3. [CrossRef]
  • Park Y, Park YS, Kim SH, Oh DH, Park YC. Supplementation of n-3 Polyunsaturated Fatty Acids for Major Depressive Disorder: A Randomized, Double-Blind, 12-Week, Placebo-Controlled Trial in Korea. Ann Nutr Metab 2015;66:141-8. [CrossRef]
  • McLeod MN, Golden RN. Chromium treatment of depression. Int J Neuropsychopharmacol 2000;3:311–4. [CrossRef]
  • Davidson JR, Abraham K, Connor KM, McLeod MN. Effectiveness of chromium in atypical depression: a placebo-controlled trial. Biol Psychiatry 2003;53:261–4.
  • Lang UE, Borgwardt S. Molecular mechanisms of depression: perspectives on new treatment strategies. Cell Physiol Biochem 2013;31:761-77. [CrossRef]
  • Bertone-Johnson ER, Hankinson SE, Forger NG, Powers SI, Willett WC, Johnson SR, et al. Plasma 25-hydroxyvitamin D and risk of premenstrual syndrome in a prospective cohort study. BMC Womens Health 2014;14:56. [CrossRef]
  • Hoang MT, Defina LF, Willis BL. Association between low serum 25-hydroxyvitamin D and depression in a large sample of healthy adults: the Cooper Center longitudinal study. Mayo Clin Proc 2011;86:1050–5. [CrossRef]
  • Yüksel RN, Altunsoy N, Tikir B, Cingi Külük M, Unal K, Goka S, Aydemir C, Goka E. Correlation between total vitamin D levels and psychotic psychopathology in patients with schizophrenia: therapeutic implications for add-on vitamin D augmentation. Ther Adv Psychopharmacol 2014;. 4: 268–75. [CrossRef]
  • McGrath J, Saari K, Hakko H, Jokelainen J, Jones P, Järvelin MR, et al. Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study. Schizophr Res 2004;67:237–45. [CrossRef]
  • Munoz CX, Johnson EC, McKenzie AL, Guelinckx I, Graverholt G, Casa DJ, et al. Habitual total water intake and dimensions of mood in healthy young women. Appetite 2015;92:81–6. [CrossRef]
  • Zhao G, Ford ES, Li C, Tsai C, Dhingra S, Balluz LS. Waist circumference, abdominal obesity, and depression among overweight and obese U.S. adults: national health and nutrition examination survey 2005- 2006. BMC Psychiatry 2011; 11: 130. [CrossRef]
  • Raheja UK, Fuchs D, Giegling I, Brenner LA, Rowner SF, Mohyuddin I, Weghuber D, Magge H, Rujescu D. In psychiatrically healthy individuals, overweight women but not men have lower tryptophan levels. Pteridines 2015; 26:79–84. [CrossRef]
  • Özenoğlu A, Ünal G. Açlık ve Şiddet. MÜSBED 2015;5:115-22. [CrossRef]
  • Voracek M, Tran US. Dietary tryptophan intake and suicide rate in industrialized nations. J Affect Disord 2007;98:259-62. [CrossRef]
  • Lankelma JM, Nieuwdorp M, de Vos WM, Wiersinga WJ. The gut microbiota in internal medicine: implications for health and disease. Neth J Med 2015;2:61-8.
  • Oriach CS, Robertson RC, Stanton C, Cryan JF, Dinan TG. Food for thought: The role of nutrition in the microbiota-gut-brain axis. Clinical Nutrition Experimental 2016; 6: 25-38. [CrossRef]
  • Dinan TG, Stanton C, Cryan JF. Psychobiotics: a novel class of psychotropic. Biol Psychiatry 2013;74:720-6. [CrossRef]
  • Cani PD, Delzenne NM. The gut microbiome as therapeutic target. Pharmacology and Therapeutics 2011: 130: 202–12. [CrossRef]
There are 44 citations in total.

Details

Primary Language Turkish
Journal Section Collection
Authors

Aliye Özenoğlu

Publication Date December 1, 2018
Published in Issue Year 2018Issue: 4

Cite

EndNote Özenoğlu A (December 1, 2018) Duygu durumu, Besin ve Beslenme İlişkisi. Acıbadem Üniversitesi Sağlık Bilimleri Dergisi 4 357–365.